Latest Strategic Growth News

Dexus Industria REIT reported a 19.3% drop in net profit for H1 FY26 but edged up its full-year FFO guidance, underpinned by strong leasing and a robust development pipeline.

Santos Limited reports a stable 2025 reserves position with a 17-year life and significant growth in CO2 storage capacity, underpinning its decarbonisation strategy. The company also provides preliminary guidance on its 2025 financial results.

Evolution Mining has approved nearly $800 million in capital investments across key projects, aiming to boost production and returns significantly. The company also expands its exploration footprint in Canada, signaling a robust growth strategy.

Evolution Energy Minerals Limited has announced a renounceable pro-rata entitlement offer to raise up to $4.03 million, aiming to fund exploration and development of its Tanzanian copper and graphite assets. The offer includes free attaching options and is partially underwritten, reflecting both opportunity and risk amid regulatory challenges.

Elanor Investors Group has secured securityholder approval for a $125 million recapitalisation with Rockworth Capital Partners and the acquisition of Firmus Capital, marking a pivotal step in stabilising its balance sheet and positioning for growth.

Electro Optic Systems (EOS) has firmly rejected allegations from a recent Grizzly Research report, highlighting its strengthened financial position, significant contract wins, and strategic acquisition to bolster its defence technology portfolio.

Brightstar Resources has launched a $5 million Share Purchase Plan offering eligible shareholders discounted shares to fund key mining projects. The offer opens on 10 February and closes on 27 February 2026.

Reckon Limited has reported a robust 66.7% increase in net profit for the 2025 financial year, driven by strong revenue growth and the acquisition of Cashflow Manager. The company maintains its dividend policy amid expanding subscription revenues.

CAR Group has reported strong first-half results for FY26, with double-digit revenue and earnings growth across all key regions, underpinned by strategic AI investments and expanding market presence.

Conico Ltd is set to raise $85,000 through a follow-on share placement at $0.008 per share, targeting strategic shareholders to meet excess demand from its recent entitlement offer.

Epsilon Healthcare’s subsidiary, Epsilon Pharma, has signed a three-year manufacturing agreement with New Zealand’s Puro to supply medicinal cannabis products to the UK and Europe, marking a significant step in its international expansion.

Regal Partners has launched a $75 million on-market share buy-back program, signalling strong confidence in its financial health and growth prospects. The buy-back aims to enhance shareholder value while preserving capital for strategic opportunities.